BSVSX
Price
$15.98
Change
+$0.06 (+0.38%)
Updated
Aug 15 closing price
Net Assets
75.89M
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

BSVSX vs VSCPX

Header iconBSVSX vs VSCPX Comparison
Open Charts BSVSX vs VSCPXBanner chart's image
Baird Equity Opportunity Investor
Price$15.98
Change+$0.06 (+0.38%)
VolumeN/A
Net Assets75.89M
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
BSVSX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BSVSX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSVSX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. BSVSX (75.9M). VSCPX pays higher dividends than BSVSX: VSCPX (1.39) vs BSVSX (0.01). BSVSX was incepted earlier than VSCPX: BSVSX (13 years) vs VSCPX (15 years). BSVSX (1.98) is less costly to investors than VSCPX (0.03). BSVSX is a more actively managed with annual turnover of: 76.00 vs. VSCPX (13.00). BSVSX has a lower initial minimum investment than VSCPX: BSVSX (2500) vs VSCPX (100000000). BSVSX annual gain was more profitable for investors over the last year : 17.68 vs. VSCPX (9.18). VSCPX return over 5 years is better than : 57.76 vs. BSVSX (16.27).
BSVSXVSCPXBSVSX / VSCPX
Total Expense Ratio1.500.035,000%
Annual Report Gross Expense Ratio1.980.036,600%
Fund Existence13 years15 years-
Gain YTD-1.2972.528-51%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets75.9M154B0%
Annual Yield % from dividends0.011.390%
Returns for 1 year17.689.18193%
Returns for 3 years-6.3220.50-31%
Returns for 5 years16.2757.7628%
Returns for 10 years17.21113.1915%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune